Anna Boula

Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma

Michael G. Alexandrakis, Freda Passam, Anna Boula et al. · Annals of Hematology · 2003 · 60 citations

Inflammation, Cytokine, Angiogenesis +9

Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma

Michael G. Alexandrakis, Nektaria Goulidaki, Constantina A. Pappa et al. · Pathology & Oncology Research · 2015 · 56 citations

Inflammation, Cytokine, Hematological Malignancy +6

B cell-activating factor: its clinical significance in multiple myeloma patients

M. Fragioudaki, Anna Boula, George Tsirakis et al. · Annals of Hematology · 2012 · 30 citations

Hematological Malignancy, B Cell-activating Factor, Hematology +5

Effect of cA2 Anti–Tumor Necrosis Factor-α Antibody Therapy on Hematopoiesis of Patients with Myelodysplastic Syndromes

Anna Boula, Michael Voulgarelis, Stavroula Giannouli et al. · Clinical Cancer Research · 2006 · 27 citations · Full text

Relationship between Circulating BAFF Serum Levels with Proliferating Markers in Patients with Multiple Myeloma

Michael G. Alexandrakis, P Roussou, Constantina A. Pappa et al. · BioMed Research International · 2013 · 24 citations · Full text

Hematological Malignancy, Tumor Biology, Oncology +13